Additionally, TGFB2 (Transforming Growth Factor Beta 2) has been identified as a predictor of poor treatment outcomes in pediatric diffuse intrinsic pontine glioma [24]. This evidence concerns the gene TGFB2 and diffuse intrinsic pontine glioma.